Strengthening pharmaceutical self‑reliance
Strengthening pharmaceutical self‑reliance
The key outcomes and the details regarding companies, incentive outlays and domestic capacity added since inception are as follows:
The Department of Pharmaceuticals is implementing the scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP), with financial outlay of ₹5,000 crore. Under this, seven Centres of Excellence (CoEs) have been set up, one at each of the seven National Institute of Pharmaceutical Education and Research, with total budgetary outlay to the tune of ₹700 crore, for creating research infrastructure and promoting R&D in identified areas. Till July 2025, CoEs have approved 106 research projects.
The Government is actively working to integrate India’s Ayush systems with the global health intervention framework. The establishment of Global Traditional Medicine Centre of World Health Organization (WHO) at Jamnagar serves as an international hub for research, innovation and policy dialogue on traditional medicine. Further, a Memorandum of Understanding has been signed with WHO in May 2025 for developing the International Classification of Health Interventions module to facilitate standardised global coding of AYUSH interventions. These platforms are meant to enhance international acceptance, improve clinical data comparability and support integration of Ayush into public health systems, with phased outcomes in the future.
This information was given by the Union Minister of State for Chemicals and Fertilizers Smt Anupriya Patel in Rajya Sabha in reply to a question today.
*****
- PLI Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs) / Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India (also known as the PLI Scheme for Bulk Drugs): The objective of the scheme is to improve self-reliance and reduce import dependence in critical KSMs, DIs and APIs. The scheme has a total financial outlay of ₹6,940 crore. 32 companies/pharmaceutical entities have been selected for greenfield production through 48 projects involving 33 APIs/DIs/KSMs. Key outcomes, as of June 2025, include the following: